Torthaí cuardaigh - Ketteler, Markus
- 1 - 20 toradh as 58 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Phosphate Metabolism in CKD Stages 3–5: Dietary and Pharmacological Control de réir Ketteler, Markus
Foilsithe / Cruthaithe 2011Téacs -
2
14. Recent Approaches to Therapy: Is There Real Progress? de réir Ketteler, Markus
Foilsithe / Cruthaithe 2009Téacs -
3
Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease de réir Ketteler, Markus, Ambühl, Patrice
Foilsithe / Cruthaithe 2021Téacs -
4
-
5
-
6
Magnesium basics de réir Jahnen-Dechent, Wilhelm, Ketteler, Markus
Foilsithe / Cruthaithe 2012Téacs -
7
-
8
-
9
Management of hyperphosphataemia in chronic kidney disease—challenges and solutions de réir Ketteler, Markus, Wüthrich, Rudolf P., Floege, Jürgen
Foilsithe / Cruthaithe 2013Téacs -
10
-
11
Atypical case of AL amyloidosis with urinary erythrocyte casts de réir Liangos, Orfeas, Buettner-Herold, Maike, Ketteler, Markus, Madias, Nicolaos E.
Foilsithe / Cruthaithe 2015Téacs -
12
Phosphate Additives in Food—a Health Risk de réir Ritz, Eberhard, Hahn, Kai, Ketteler, Markus, Kuhlmann, Martin K, Mann, Johannes
Foilsithe / Cruthaithe 2012Téacs -
13
-
14
Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients – Data... de réir Rothe, Hansjörg, Brandenburg, Vincent, Haun, Margot, Kollerits, Barbara, Kronenberg, Florian, Ketteler, Markus, Wanner, Christoph
Foilsithe / Cruthaithe 2017Téacs -
15
Association Between Human Fetuin-A and the Metabolic Syndrome Data From the Heart and Soul Study de réir Ix, Joachim H., Shlipak, Michael G., Brandenburg, Vincent M., Ali, Sadia, Ketteler, Markus, Whooley, Mary A.
Foilsithe / Cruthaithe 2006Téacs -
16
Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide de réir Covic, Adrian C., Floege, Jürgen, Ketteler, Markus, Sprague, Stuart M., Lisk, Laura, Rakov, Viatcheslav, Rastogi, Anjay
Foilsithe / Cruthaithe 2017Téacs -
17
Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation de réir Floege, Jürgen, Funk, Felix, Ketteler, Markus, Rastogi, Anjay, Walpen, Sebastian, Covic, Adrian C, Sprague, Stuart M
Foilsithe / Cruthaithe 2020Téacs -
18
Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study de réir Covic, Adrian C., Sprague, Stuart M., Rastogi, Anjay, Ketteler, Markus, Walpen, Sebastian, Perrin, Amandine, Floege, Jürgen
Foilsithe / Cruthaithe 2020Téacs -
19
Association of Fetuin-A With Mitral Annular Calcification and Aortic Stenosis Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study de réir Ix, Joachim H., Chertow, Glenn M., Shlipak, Michael G., Brandenburg, Vincent M., Ketteler, Markus, Whooley, Mary A.
Foilsithe / Cruthaithe 2007Téacs -
20
Fetuin-A and kidney function in persons with coronary artery disease—data from the heart and soul study de réir Ix, Joachim H., Chertow, Glenn M., Shlipak, Michael G., Brandenburg, Vincent M., Ketteler, Markus, Whooley, Mary A.
Foilsithe / Cruthaithe 2006Téacs